Ultrasound-Guided Proximal Superior Cluneal Nerve Block for SCNE
Official title: Clinical Outcomes of Ultrasound-Guided Proximal Superior Cluneal Nerve Block in Patients With Superior Cluneal Nerve Entrapment
Run by Gaziosmanpasa Research and Education Hospital · NCT07712406 · Data updated 2026-11-12
This study tests how well an ultrasound-guided nerve block works for people with superior cluneal nerve entrapment and chronic low back pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Gaziosmanpasa Research and Education Hospital Government |
| Locations | 1 site (Gaziosmanpaşa, Istanbul) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07712406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-75 with chronic low back or gluteal pain, localized tenderness over the posterior iliac crest, and at least a 50% pain reduction after a diagnostic SCN block.
✕Probably not a fit
Patients who do not experience pain relief after the diagnostic block or have contraindications to the procedure may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational cohort study will enroll adults with clinically diagnosed superior cluneal nerve entrapment who undergo ultrasound-guided proximal superior cluneal nerve block as part of routine care. Researchers will measure pain intensity, disability, and neuropathic pain features at baseline, 1 month, and 3 months after the procedure using validated outcomes. The primary goal is to see how pain changes after the nerve block; secondary goals include changes in disability and neuropathic pain characteristics. The study aims to provide prospective data on the clinical outcomes of this technique when used in real-world practice. Eligibility includes adults 18-75 with chronic low back/gluteal pain and a positive response to a diagnostic SCN block.
Why it matters
Potential benefit: If successful, patients may experience meaningful reductions in pain and disability after the nerve block.
How similar studies have gone: Ultrasound-guided nerve blocks have shown benefits in similar peripheral nerve entrapment conditions, but prospective data for SCNE are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-75 years. * Chronic low back and/or gluteal pain persisting for at least 3 months. * Localized pain and/or tenderness over the posterior iliac crest. * At least 50% reduction in pain intensity following diagnostic superior cluneal nerve block. * Failure of conservative treatment. * Ability to provide written informed consent. Exclusion Criteria: * Previous superior cluneal nerve surgery. * Active local or systemic infection. * Bleeding disorders or contraindications to the procedure. * Allergy to study medications. * Pregnancy. * Severe cognitive impairment or inability to complete study assessments. * Additional interventional pain procedures involving the affected region during follow-up.
Where it's running
-
Gaziosmanpasa Research and Education Hospital
Gaziosmanpaşa, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Tuğçe Yavuz Mollavelioğlu, Medical Doctor
- Email: tugceyavuz@hotmail.com.tr
- Phone: +905056751666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.